Will AI ever cure cancer? The multibillion-dollar race to bring the first AI-discovered drug to market

Quick Summary:

Recursion Pharmaceuticals—a relatively small company backed by the chip giant Nvidia—is betting that its massive supercomputer will give it the edge to dominate the sector.

Much like OpenAI shoveling the world’s text into a large language model to create ChatGPT, Recursion believes that by feeding its fast-accumulating cellular and medical data to BioHive-2, it can break open biology—providing the insights, long elusive to humans, needed to understand hard-to-treat conditions from cancer to neurodegenerative and autoimmune diseases.

But the vision of companies like Recursion is grander than that: Their bet is that by pairing massive amounts of scientific data with powerful new computing tools, AI can unlock the mysteries of biology and design drugs to cure the diseases we’re plagued by.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Author / Journalist: Erika Fry

Category: EconomyBusiness

Markets: United States

Topics: Biotech Health Disease Medicine A.I. Pharmaceutical Industry

Source Website Secure: Yes (HTTPS)

News Sentiment: Neutral

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-04-03 @ 10:00:00 (1 days ago)

News Timezone: GMT +8:00

News Source URL: fortune.com

Language: English

Article Length: 3692 words

Reading Time: 21 minutes read

Sentences: 6 lines

Sentence Length: 616 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Fortune

News ID: 27561094

View Article Analysis

About Fortune

Main Topics: EconomyBusiness

Official Website: fortune.com

Update Frequency: 39 posts per day

Year Established: 1929

Headquarters: United States

News Last Updated: 9 hours ago

Coverage Areas: United States

Ownership: Independent Company

Publication Timezone: GMT +8:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #95

Publisher Details

Frequently Asked Questions